Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation
- Conditions
- Drug DoseCalculated SAPCirculation
- Interventions
- Other: Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation
- Registration Number
- NCT02201121
- Lead Sponsor
- Chinese PLA General Hospital
- Brief Summary
Although induced hypertension decreased SVV and PPV,the influences of stroke volume variation and pulse pressure variation caused by phenylephrine,dopamine and ephedrine were unknown.
- Detailed Description
Pulse pressure variation (PPV) and stroke volume variation (SVV) during mechanical ventilation have been shown to be effective parameters to predict preload responsiveness. Although induced hypertension decreases PPV and SVV, the influences of phenylephrine, dopamine and ephedrine on PPV and SVV are unknown.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 94
- Their American Society of Anesthesiologists (ASA) physical status was 1 or 2
- Body mass index (BMI) ranged from 18 to 26
- None of the patients had known diabetes mellitus, hypertension, cardiovascular, pulmonary, endocrinological, neurological diseases, or diseases that influenced intravascular fluid volume or balance
- All patients had a preoperative fast for at least 8 h and routine atropine intramuscular injection
- Persistent arrhythmias
- Intraoperative application of vasoactive drugs except phenylephrine, dopamine and ephedrine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description phenylephrine group, dopamine group, ephedrine group Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation phenylephrine group: use the phenylephrine to increase the SAP from low to high level. dopamine group: use the dopamine to increase the SAP from low to high level. ephedrine group:use the ephedrine to increase the SAP from low to high level.
- Primary Outcome Measures
Name Time Method invasive arterial blood pressure as a Measure of Safety DAY 1 if instability of circulation, stop the clinical trial
- Secondary Outcome Measures
Name Time Method